Entropica develops software that will identify how variations in DNA lead to the occurrence of a phenotype, such as an adverse drug reaction or a disease. This will enable researchers and clinicians working in pharmaceutical companies and healthcare institutions to develop new medicines and design tailored treatments. In the future, Entropica will use its software to discover novel therapeutics in-house.